Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
Natália Sousa Freitas Queiroz, Luísa Leite Barros, Matheus Freitas Cardoso de Azevedo, Jane Oba, Carlos Walter Sobrado, Alexandre de Sousa Carlos, Luciane Reis Milani, Aytan Miranda Sipahi, Adérson Omar Mourão Cintra Damião
Abstract
The world is fighting the COVID-19 outbreak and health workers, including inflammatory bowel diseases specialists, have been challenged to address the specific clinical issues of their patients. We hereby summarize the current literature in the management of inflammatory bowel disease (IBD) patients during the COVID-19 pandemic era that support the rearrangement of our IBD unit and the clinical advice provided to our patients.
Topics & Concepts
Inflammatory bowel diseaseMedicinePandemicCoronavirus disease 2019 (COVID-19)ReferralOutbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicineDiseaseInflammatory Bowel DiseasesInternal medicineFamily medicinePathologyInfectious disease (medical specialty)COVID-19 and healthcare impactsInflammatory Bowel DiseaseCOVID-19 Clinical Research Studies